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In the present study, we examined the cytokine pat-
t ern expressed i11 situ during the development of 
eczematous reactions that had been provoked in 
atopic dermatitis patients by patch testing with house 
dust mite allergen. In 24-h house dust mite allergen 
patch test reactions, expression of interleukin (IL)-4 
mRNA and IL-2 mRNA increased, but interferon 
(IFN)-y mRNA did not, as compared with control 
skin. In 48-h inhalant allergen patch test reactions, 
however, IFN-y mRNA and IL-2 mRNA expression 
-were increased above levels observed in control skin, 
whereas IL-4 mRNA expression was decreased below 
background levels. These data demonstrate that a 
switch from a Th2-like to a Thclike cytokine re-
sponse occurs in inhalant allergen patch tests of 
atopic dermatitis patients. This biphasic pattern was 
T he re is increasing evide nce that the basis of atopic dermatitis is immunologic in n a ture and that a dys-regulated , cytokine-media ted respo nse of the skin immune system to en vironmental all ergens is an important pathogene tic fa ctor (1,2]. 
Eczematous skin lesions in atopic de rmatitis p atie nts contain 
cyt o kine-produ cing , C D 4-posi tive T cells (3,4). In the mouse 
m odel , CD4-positive T cell s or T-helper cell s (T h cells) have been 
divided into tw o subclasses depe nding on their cytokin e secre tion 
patte rn: the Th'1-like subtype , which is charac te1;zed by predo mi-
nant production of in terfe ron (JFN)-y and inte rle uk:in (I L)-2, and 
th e Th2-like subtype, which typi cally synth esizes IL-4 [5]. Al-
tho ugh the cytokin e profil e is more heterogeneou s, a similar 
divi sion into Th 1- and Th 2-like subtypes is a lso frequentl y present 
in humans (6,7]. In previous studies, 85'Y,1 o f skin samples obtained 
from chronjc eczem ato us lesions of a to pi c derm atiti s patien ts w ere 
fo und to contain increased le vels of IFN-y mRNA, whereas 
incr eased IL-4 mRN A expt·essio n could be observed in only 25% to 
30% [8] . In addition , in those ato pic dermatitis patients wh ose skin 
d isease responded to treatment, in creased IFN-y mRNA but not 
incr eased IL-4 mRNA le ve ls w ere do w n-regu lated . These studi es 
indicate that the Th 1-like cytokine I FN-y plays a major ro le in the 
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specific to inhalant allergen patch test reactions, as it 
was not observed in irritant reactions in the same 
patient. IFN-y production by T cells may be induced 
by the cytokine IL-12. In the present study, up-
regulation of IFN-y mRNA expression in inhalant 
allergen patch test reactions was preceded by an 
increased expression of the p35 subunit of IL-12 
tnRNA. These observations suggest that increased 
IL-12 expression may contribute to the observed 
switch of the i11 situ cytokine secretion pattern. Fur-
ther studies are necessary to determine whether a 
similar biphasic pattern of cytokine expression is also 
operative in the initiation phase of atopic eczema. 
Key woJ•ds: i11te~fero11-'}'linteJ•Ieukirr-4/ it~terleukiu- 12/aeJ•oal­
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m aintenance o f chronic eczemato us les ions in atopic dermati tis 
patients. 
Li ttle is known about th e cytokine pa tte rn expt·essed i11 sit11 
dUJ;n g the initiation phase o f atopic eczema. T hese studi es are 
difficult because it is virtually impossibl e to ob ta in biopsy sp ecimen s 
from atopic de rmatitis patients at de fin ed time points during thi s 
early ph ase of disease, whjch includes the tim e inte rval from 
allergen exposure to the clini cal martifes tati o n o f eczema . It is 
possible, ho wever, to induce eczem atous skin lesio ns in a to pic 
de rmatitis patients by epicutan eous appli cation o f inhalan t allergens 
to whjch these pa tients are sensitized [9 ; 1 OJ. T h e specific natu re o f 
su ch patch tes t reac tions has been sugges ted by the dem o nstration 
of a high p ercen tage of all e rgen-specifi c T cells within positive skin 
tes t les ions (11 , 12]. Altho ugh there are limitation s to usin g tl1e 
inha lant allergen patch test as a mod el for atopic eczema , it is o ne 
approach fo r studying the initiatio n phase o f thi s di sease. In the 
present study, w e examin ed skin specimens ob tained durin g th e 
de velo pment of positive inhalant alle rgen patch tes t reac tions in 
atopic dennati tis p atients for mRNA ex press ion o f th e T h 1-l.ike 
cytokine s IFN-y and IL-2 and the T h2-Like cytokine lL-4. W e also 
studied i11 situ mRNA express ion of th e cytokin e IL-12 , which IS 
capable of indu cing IFN-y pro ductio n by Tb 1 cells [1 3-16]. 
MATERlALS AND METHO DS 
Patients Five pa tients wi th atopic dennatiti s were studied after obta injng 
informed consent. All five patients were in clinical remission at the 
beginning of the study. The diagnosis of atopic dermatitis was made 
according to the cri teria of Hanifi n and R.ajka [1 7]. All fi ve pa tien ts showed 
an in1n1edia tc-typc skin reacti o n to ho use dust n1itc a iJ c rgcn. as determined 
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by intracutaneous testing with a commercial house dust m ite allergen 
preparation fro m DenunfoJ>il ngoidcs J>ferouyssiuus (Schering/ ALK. Hamburg, 
Germany) . In addition , all live patients showed a pos iti ve reactio n upon 
patch testing o f the identical allergen solution. :ts fo llows. 
Inhalant Allergen Patch Testing Epicuta neous patch tests we re ap-
plied with Leucotest chambers {Beicrsdorf, Hamburg, Ge rmany) on clini-
ca ll y normal skin on the back, as described pre vio usly [1 01. Before 
app]jcatio n of patch tests, mos t of the stratum corne um was stripped off by 
10 app ljcations of ad hesive tape (Lcukosil k ; ll eiersdod). Patch tests used 
lyo phili zed preparations (50 /.d ) of DtTIII ntoplwgoides ptcmuyssiuus (Sc hering/ 
ALK). wh i ·h were di sso lved in steri le water con ta ining (J.03'X, human serum 
albumin . The concentratio n o f the all ergen pre paration used fo r patch 
testi ng \·Vas 1 00 tin1cs the concen tratio n used for intrac utaneous testing . 
These prep<1rat:io ns did not induce skin symptoms in nonatopic individuals 
(n = 5). T he d iluents alo ne were used as negative contro ls. All patch test 
reactions we re read after. 20 m in and 24 and 48 h . Patch test reactions 
showing erythe ma wi th induration or pap ules, or both, were recorded <lS 
pos itive. As co ntro ls, two of the live patients were also patch tes ted w ith 3% 
sodium dodecylsulfate to provoke an irri ta nt reaction. 
Biopsies and RNA Extraction Four- mi llim ete r punch biopsy speci-
m ens were taken from positi ve patch test 1·eactions 24 and 48 h after 
appli cation of the patch tests. As controls . specimens w ere obta ined fro m 
vehicle-tes ted sk;n , irritan t-tested skin {two of li ve patients at 24 h and 48 
h) , and nontested skjn fi·om the same ind ividuals. T he specimens were 
was hed two times in 0.9% NaCl for 20 seconds to re move blood and were 
then snap-frozen in liqu id nitrogen . Frozen bi opsy specime ns were ground 
to powder, and to tal RNA was extracted by a modifi ed acidic chloroform/ 
phenol method ll BJ. Tota l RNA was washed and pell cted three times in 
70'){, e tha no l and then ro utinely taken up in 200 IJ. I aqua bidest . 
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
Cytokine mH . .NA expression was measured by differe ntial RT-PC R and was 
carried o ut as described prev iously [8l Quantifrca tio n of PCR products , 
detcnnination of lin ear antpiifi cation ran ges ·with regard to cycle nun1bcrs 
and the amou nt of eD NA subjected to PC R., and ca lcu lation procedures 
ha ve been described in d eta il Jl 9] . Spccifocall y, tota l RNA was reverse-
transcribed usin g n1ousc n1aloncy lcuken1ia virus reverse transcriptasc and 
an o ligo-dT 1" prim er. In brief, identical amo un ts of eDNA were subjected 
to increasing cyc le ncombers of PC R to obta in the li nea r amplifi cation range , 
and then increasing amoun ts of eDNA (for up ro (>4-fo ld of the starting 
amo unt) were subjected to PC R o f a given cycle number within t he line"r 
range to exclude the possibi li ty tha t increased mno unts of a specifi c eDNA 
lead to di sturbance of the linearity in PC R. ampljfication. Amplification was 
fo und to be linear for up to 31 cycles for the cyto kine primer pajrs and for 
up to 26 cycles for the /3-actin primer pair. For estima tion of simi lar amo un ts 
of eDNA used for PC R., samples were screened for express ion of /3-actin as 
a "housekeeping" gene. A sample (J of 200) of total eDNA was ro utinely 
subjected to 24 PC R cycl es (whjch was within the Un ea r :o m pli fi cation ran ge 
fo r cycle numbers) usin g a primer pair for /3-ac tin and subjected di rectly to 
io n-exchange chromatograp hy connected to an on- line ultra vio let spectro-
photometer (Gynkotek, Germering, Germany), w ltich allowed exact q uan-
tifi cation o f amp li fi cation products at 260 nm. Relative amo unts of e DNA 
o f each sample to be inserted into J>C [t were calcu lated to yield similar 
amounts o f fl-a ctin PC R products, and this was confi rmed by repeating 
R. T-PC R. fo r /3-actin w ith the calculated amount of e DNA . 
To investiga te cytok in c 1n RNA ex pressio n , we inserted five tin1cs tno rc 
eDNA than fo r /3-actin PC Tt. PC P... was ca rri ed o ut with 213 cycles, which 
was within the linear amplifi cation range for all cytokine cDN As . T he 
fo llowing primer pairs spec ifi c for IFN-y. IL-2 , IL-4, the p35 and p40 
subunjrs of IL- 12 . and /3-actin w ere used (5'-3'): IFN-y: AGTTATAT-
CTTGGClTITCA, ACCGAATAATTAGTCAGcn·; 11~2 : ACTCACC-
AGGATGCTCACAT, AGGTAATCCATCTGTTC AGA; I.L-4: CTTCC-
CCCTCTG"ITCTTCCT. TTCCTGCCGAGCCGTTTCAG; IL-12 p35 
subunit: ACCCAGGAAT GTf'CCCATGC, T C TGTCAATAGTCACTGC-
CCG; IL- 12 p40 subunit: AAAGGAGGCGAGGlTCTAAGCC. TTTGCG-
GCAGATGAC GTGG; <md {3-actin: GTGGGGCGCCCCAGGC ACCA, 
CTCClTAATGTC ACGCACGAlJTC. 
Parallel to each cytokinc PC P .. , a PC R. fo r /3-acti n also was performed as 
described above. Furthermore, each PC R of each sample for each cytok.ine 
was carri ed out at least two times. Products were quantified by ion-
e xchange chromatograph y as described above J8, 19 J. T o ensure identity of 
prod ucts. we co ll ected the ir chro matogra tn peaks ;.md digested thcrn with nn 
appropriate restriction endonuclea,e. and fra gments were visuali zed on 
aga rose gel by ethidium bromide sta ining. Lengths of the restri ction 
fragm ents were cnmparcd with those ded uced Ji·o m pub lished mR.NA 
sequences of the respective cytokines by using PC/GEN E software. release 
6.70 (lnte ll igencli cs Inc., Mo untain View , C A). 
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Figure 1. Expression of cytokine mR.NA for IL-4 and IFN-y during 
patch testing of atopic dermatitis patients w ith house dust mite 
allergen . Patch testing was perfo rmed as described in MnttTinls rmd Mct lwds. 
Four-mill imeter puncb b iopsy spec imens were take n fro m positive patch 
test reactio ns 24 and 48 h after application of the patch tests. As controls. 
cytokine mR . .NA expression was assessed in vehicle-tested skin at the same 
times and did not di.ffer fro m no ntcsted skin {at 0 h) by m ore than l O% (da ta 
not shown). Extraction of RNA. RT-PC R., and semiquanti tative RT-PC R. 
ana lyses were performed as described in Mntcrinls mill Methods. T he mR.NA 
expression of no ntested skin was arbitrari ly set at 100%. Data arc shown as 
hi stograrns o f rela tive cytokin c n1R...NA expre ssion vers us tin1c . Triaugles, 
IL-4 mR.NA; circles, IFN-y mRNA . Data represent m e<nl ::':: SD of li ve 
patients. 
RESULTS 
Ex pressio n of lL-4, lFN-y, lL-2, IL-12 p35, and IL-12 p40 mR.NA 
i n 24 -h and 48-h vehicl e-tested contro l skin of patien ts w ith atopic 
d e rma t iti s (n = 5) r esulte d in low amplifi cation produ c ts, w hic h did 
n ot diffe r from those o btnined in n o nlesio n a l, nontested skin from 
the same individuals. In all five patie nts examine d , 24-h house dust 
m ite a llergen patch test lesion s were c h arac terized b y enha n ced 
ampl ifi cation signals fo r IL- 4 mR.N A. w h ereas ampli fic a tion signals 
fo r lFN-y mR.N A were d ecreased (Fig 1). In con t rast , assess m ent 
of cytok in e expression in 48-h house d u st mite a ll e rge n patch test 
reactions in these patie nts reveale d en h an ced amp li fi c atio n signal 
for l FN-y mRNA, w h e reas IL- 4 mR.NA express io n was down-
regula ted b e low th e levels t h at w e re o b served in con tro l skin (Fig 
1). As co m pared with control ski n , the ratio of fL-4 to IFN-y 
mR.NA was in c reased in 24-h p :ttc h test re<~ ct i on s by a fac to r of 5, 
b u t w as d ecreased approximate ly sevenfo ld in 48-h lesion s. 
IL-2 mRNA expression was in vestigated in three patie nts . IL - 2 
mR.NA ex press ion was found to b e inc reased in both 24-h and 48-h 
a ll e rgen pa tch test reac tions as compared with vehicle-tested 
co ntro l skin (Fig 2) . 
Express io n of th e p 35 subunit of I L- 12 mR..NA was studied in 
fo ur patients. T hi s mR.NA was in c reased in 24-h and 48-h patch 
test les io n s, whereas express ion of th e p40 subunit of fL-12 mR.NA 
was d ecreased at b o th time points below the levels o b se rved in 
contro l skin (Fig 2) . 
To assess th e specific ity of th e obse rved cytokine p atte rns fo r 
in h a lant a ll e rgen patch tests, biopsy specimen s obtained fi·o m 24-h 
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F igure 2. Expression of cytokine mRNA for IL-2 and IL-12 during 
patch testing of atopic dermatitis patients with house dust mite 
allergen. Patch testing was performed as described in i\1/arerin/s lllllf Mct!tods . 
Four-mi llimeter punch biopsy specimens were taken from positive patch 
test reactions 2<1 and 48 h after application of tht' patch tests. As controls, 
cytokinc mRNA expression was assessed in vehicle-tested skin at the sa me 
times a.nd did not diOcr from non tested skin (at 0 h) by more than 1 O'X, (data 
not shown). Ex traction of RNA. RT-PC R, and semiquan titative RT-PC R 
analyses were performed as described in Mntcrinls tllllf Mct!tods. T he mRNA 
expression of non tested skin was arbitraril y set at l 00%. Data arc shown as 
histogr:uns of rela tive cy tokine mRNA cxprcssiou versus time and represent 
mean ::!: SO of three IL-2 (squares) and four IL-·12 p35 (closet/ dinutoutls) and 
lL-12 p40 (ope11 dinmomls) pa tients. 
and 48-h irri tan t patch test reactions performed in two of the fiv e 
patients were screened for IL-4 , I.L-2 , and IFN- ')' mR.NA expres-
sion as controls . I.FN-')' mR.N A express io n, in contrast to inhalant 
allergen patch tests, was alread y m oderately increased in 24-h 
irritant patch tests and was furthe1· up-regulated at 48 h (Fig 3). 
Similar kinetics were observed fo r IL-2 mRNA expression. In 
contrast, IL-4 mRNA expression did no t reveal s igni~l cant changes 
in 24-h and 48-h irritant patch test reac tio ns compared with 
vehicle-tes ted or nontested skin. No increase of IL-4 milNA 
expression was observed i.n 24-h irri tant patch test reactions. 
DISC USSION 
We have de monstrated inc reased i11 sit11 mRNA expression of the 
T b 2-like cytokin e JL-4 in 24-h inhalant allergen patch test reactions 
of patients with atopic de rmati tis . T his observation is in agreement 
wi th previo u s studies in w hich intracutaneous application of inhal-
ant allergens into the skin of a topic individuals was assoc iated wi th 
increased milNA expression of the cytokine gen e cluster !L-3, 
IL-4, IL-5, and granul ocyte-macrophage co lony- stimulating facto r 
[20). ln contract, LFN-y mRNA appeared to be decreased be low 
the levels observed in con tro l skin , probabl y as a result of the 
suppressive effect ofTh2- cell-derived cytokin es o n IFN- ')' expres-
sion. We conclude that the T h 2-Like cytokine IL-4, but not th e 
T b 1-like cytok.ine IFN- y, is cru cial in the ea rl y phase of positive 
inhalan t a lle rgen patch tests of atopic indi viduals. 
In contra st to 24-h inhalant allergen patch test lesions, 48-h 
inbalant allergen patch test lesions w ere ch arac terized by increased 
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Figure 3. Expression of cytokine mRNA for IL-4, IL-2, and IFN-y 
during patch testing of atopic dermatitis patients with 3% sodium 
dodecylsulfate. Patch testing was pcrfonncd as described in Mmerinls ntul 
Mctftods. Four-millimeter punch biopsy specimens were taken from positive 
patch test reactions 24 and 48 h after application of the patch tests. As 
controls, cytokinc mR.NA express ion was assessed in vehicle-tested skin at 
the same times and did not differ from nomcstcd skin (at 0 h) by more than 
·1 O'Yu (data not shown). Extraction of RNA, R T-PCR, and semiquantitative 
RT-PC R. analyses were performed as described in i\1/ntain/s ntul Mt'tft.,ds . 
T he mRN A expression of nontestcd skin was arbiu·arily set at 100%. Data 
arc sho \VII as hi stognuns of re lative cy tokinc ntll.NA express ion versus ritn c 
and represent mean ::!: SD of two patients. Tritmgles, IL-4; sq11nres, IL-2; 
cirrlcs, I FN-y. 
expressio n of IFN-')' mRN A, w he reas IL-4 express ion was de-
creased below background levels . T his d ich otomy in cyto kine 
expression between 24- and 48-h patch test reactio ns has bee n 
confirmed recently at the prote in level by an independent study. t 
Analys is of the cy to kine proftl e produced by ho use dust mite-
specific T - ce Ll clones tba t had been isolated from 48-h patch test 
lesions revea led a predominant expression of T h2- like over T h ,-
like clones [12]. Alle rgen- specifi c T cells, however, represent only 
a min or pe rcentage of the tota l number ofT cell s present in 48-h 
all ergen patch test les ions. T he presen t demonstration of inc re:1sed 
levels of JFN-')' mRNA in 48-h pa tch test lesions indi cates that the 
majority ofT cells, i.e., T h 1 and /or T h., ce ll s, presen t in 48-h patch 
test les ions arc capable of IFN-')' production . T he described bipha-
sic pattern is specific fur the inh alant all ergen pa tch test reaction, as 
we w e re not ab le to obtain a similar result fo r skin lesions provoked 
by irri tants in two of the atopic de rmatiti s patients in vestigated. In 
on e g rass-po l.l en-sensitized patient investigated for cytokinc pro-
files during patch testing w ith grass po llen allergen, essentiall y 
identica l data were obtained w ith regard to the expression s of 
lFN- y, IL-4, and IL-2 as described he re for house dust mite alle rgen 
(data not shown) . 
"[ Thepe T. Langcveld- Wildschu t EG, ili.hari IC, van Wichcn CF, van 
R.e[jscn FC. Mudde GC. Bruijn zeci-Koomen CAFM: 13i-phasic response 
aga inst acroall crgcn in atopic dcn11atiris showing a switch fro ru an initial 
Th2 response in to an T hl response in situ . An iriununo-cytochemical study 
(submitted). 
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If the inhalant allergen patch test is accepted as a m odel fo r the 
injtiation ph ase of ato pic eczem a, the present stud y may help to 
explain the divergent results concernin g the invo lvem ent of differ-
en t T-cell subsets in atopic ecze m a. Al tho ugh analysis of all ergen-
specifi c T -cell cl o nes deri ved fi·o m inh alan t allergen patch test 
reactio ns [11 , 12] o r atopic derm atitis lesions po ints to a crucial ro le 
fo r T h2 -li ke cells, o th er observatio ns support the ro le o f T h 1-like 
cel ls by de m onstrating an associati on between di sease activity and 
expression of IFN-')1 in lesional atopic skin L8). T hese som ewhat 
con tradictory results m ay be explain ed by the subsequent activa tio n 
of di lfe ren t T - cell sub types. W e hypo thesize that in an ea rly step , 
activation of all ergen-specific T h2 -li ke cells characterizes the initi al 
phase of p ositive inhalant allergen patch test reactio ns, whereas in 
a late r period , ac tiva ti o n of pro bable alle rgen-non specific Th 1- o r 
T h 0-like cell s o ve rcom es the early T -cell acti vatio n and leads to 
p ro m otio n and m ain tenance of positi ve skin reactio ns. It is intrig u-
in g to speculate that a simil ar sequ en tial ac tiva tio n ofT -cell subsets 
is operative in the indu ction :md main tenance o f atopic eczem a. 
IL-2 m RNA expressio n was fo und to be increased in 24-h and 
48-h patch test reactio ns. A ltho ugh p roduced by T h 1 and/ or T h0 
cells, IL-2 m ay ac t o n T h2 cells as well and thu s serve as a gro wth 
fac to r not o nly fo r human T h 1-like bu t also fo r human T h2 -Li ke 
cells [7] . IL-2 expressio n in inhalant allergen patch tes t lesions m ay 
the refore injtially suppo rt the clo nal expansion o f allergen-specifi c 
T h2- like cells but in ,;dditio n , at a later time point, the accumulation 
of T h 1-like cells. 
Increased IFN- ')1 mR.NA expressio n in 48-h inhalan t a iJe rgen 
patch test lesio ns w as preceded by increased m R.NA expression o f 
the p35 subuni t of IL-12. R ecently, the cytokin e lL-12 has been 
dem onstrated to be capable of inducin g IF N-y productio n by T h 1 
cells both i11 v it ro and in 11i 11o [1 3-1 6]. IL- 12 is a 70 - 75- kDa 
heterodimer con sisting of a sm alle r (p3 5) and a larger (p40) subunit 
[21 ,22] . Fun ctio nal studies indicate that the p35 subunit is resp on-
sible fo r IL- 12 bioactivity, servin g a ro le in sign al transduction by 
binding to m embran e- associated TL-1 2 recep tors [23 ). Alth o ugh i.11 
the presen t huma ,-; study, experiments to pro ve the ca usa l role of 
IL-1. 2 for IFN-y expression could no t be pe rformed, the kinetic 
be havio rs ofiL-1. 2 and IFN-')1 mR N A exp ressio n sugges t a cau se-
effect rcl.a tion. Further studies arc required to de termine the cellular 
source of in creased IL-1 2 express ion . 
In contra st to tbe p35 subu nit, the p40 subunit is tho ught to 
represen t a so.luble IL-12 receptor, w hich as a m o no me r m ay serve 
to inhibit IL-12 bioactivity:j: [24] . T he presen t resul ts indicate that 
the p35 and p40 subuni ts of lL-1 2 m ay be regulated in human skin 
in an inverse fashi on . T his ma y lead to excess of eith er functio nally 
ac tive heterodim ers o r p35 ho m odime rs capable o f binding to 
membrane IL-12 recep tors. 
Taken together, these studies dem o nstrate that the develo pmen t 
of skin lesions in inhalant all ergen patch test lesions in atopic 
patien ts in vo lves a switch fro m a T h2 -li kc to a T h 1-Jjke inflamm a-
tory respon se . 
T his 111ork has been .wppmted by a gm 11t fro m tl~e Ocll/sche f'orsclllmgs"~cmeill sclinft 
Kr 871 I 3-3. We thank Dr. S nsanne Gret/rcr-Beck, Oiisscldmj.for criticn lly reading 
tl1e man11script . 
t Mattncr R, Fischer S, G uckcs S, Jin S. Schmi tt E, R.i:1dc E, Gcnnan.n T. 
T he intcrl eukin -12 subunit P40 spec ifica ll y inhibits effects o f the in terle u-
kin-1 2 heterodimer (abstr) . lnllllrllwbiolosy (in press). 
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